Salcuni Pf
University of Parma
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Salcuni Pf.
Surgery Today | 2011
Renato Costi; Davide Di Mauro; Licia Veronesi; Andrea Ardizzoni; Salcuni Pf; Luigi Roncoroni; Leopoldo Sarli; Vincenzo Violi
PurposeDespite the encouraging results of chemotherapy in patients affected by incurable colorectal cancer (CRC), surgical resection of a primitive tumor is still a common approach worldwide. The identification of prognostic factors related to short survival (<6 months) may allow excluding from resective surgery those who may not benefit from it.MethodsA retrospective analysis was performed of 15 variables in a population of 71 patients undergoing nonemergency palliative primary resections of incurable CRC, including patients’ demographics and clinical/histopathological characteristics of the tumor.ResultsNo variables were related to perioperative mortality (8.5% overall). A multivariate analysis revealed that older age (≥80 years) and metastasis to more than 25% of the lymph nodes were associated with survival (4 and 6 months, respectively). Mucoid adenocarcinoma therefore tends to be associated with the prognosis (P = 0.070).ConclusionsAn elderly age tends to be a contraindication to an elective primary tumor resection in patients affected by incurable CRC. Massive lymph node involvement and mucoid adenocarcinoma should also be considered before planning major colonic surgery.
Annals of Vascular Surgery | 2014
Alessandro de Troia; Lukla Biasi; Luigi Iazzolino; Matteo Azzarone; Tiziano Tecchio; Cristina Rossi; Salcuni Pf
Endovascular treatment of posttraumatic pseudoaneurysms has become a viable less-invasive option when compared with open repair. In this study, we present a case of a posttraumatic pseudoaneurysm of the posterior tibial artery in a 34-year-old man treated with endovascular stent grafting. An extensive review of the literature has been performed.
Vascular and Endovascular Surgery | 2016
Alessandro de Troia; Francesca Mottini; Lukla Biasi; Matteo Azzarone; Tiziano Tecchio; Salcuni Pf
Infectious aneurysms of the superior mesenteric artery are a rare but life-threatening condition due to the risk of visceral ischemia, sepsis, or hemorrhage. In this study, we report the case of a superior mesenteric artery aneurysm (SMAA) secondary to a bioprosthetic valve endocarditis, successfully managed with aneurysm resection and saphenous vein interposition graft. We performed an extensive PubMed-based rewiew of the literature of the last 10 years on SMAA, which include the detection of 38 articles quoting 41 SMAAs. The case histories were divided in 2 groups: 18 cases belonged to nonmycotic group A and 23 cases were included in mycotic group B. In group A, 44.4% of patients were treated surgically, whereas in group B, 90.5%. The 2 study groups significantly differed (P = .01) in terms of surgical treatment. The surgical approach still remains the first choice of treatment in mycotic aneurysm.
Journal of Vascular Medicine & Surgery | 2015
Aless; ro de Troia; Matteo Azzarone; Tiziano Tecchio; Salcuni Pf
day’s stay in hospital the onset of fever and leukocytosis required the performance of a CTA (Computed Tomographic Angiography) (Figure 3), which showed the presence of an abscess in the surgical site. After a surgical drainage of the abscess, advanced silver medication was used to treat thigh wound; in the meantime the infection was treated with systemic antibiotics according to antibiogram. Bacterial culture test was positive for Pseudomonas areuginosa susceptible to Ceftazimide and Levofloxacin, so the elderly patient underwent intravenous antibiotics (6 g daily dose of Ceftazimide and 750 mg daily dose of Levofloxacin) for 19 days. During infection’s monitoring procedure, however, culture specimen revealed that thigh wound was positive for Escherichia Coli, Corynebacterium Jeikeium and Enterococcus faecium, susceptible to tigecycline and teicoplanin; he was thus given further intravenous antibiotics (1 g daily dose of Tigecycline and 850 mg daily dose of Teicoplanin) for 17 days. On his 46 th day’s
Journal of Clinical Anesthesia | 2006
Maria Barbagallo; A. Casati; Elisabetta Spadini; Gianluca Bertolizio; Lucy Kepgang; Tiziano Tecchio; Salcuni Pf; Angelo Rolli; Elisa Orlandelli; E. Rossini; Guido Fanelli
Journal of Cardiovascular Surgery | 1995
Salcuni Pf; Lorenzo Spaggiari; Tiziano Tecchio; Benincasa A; Matteo Azzarone
Journal of Clinical Anesthesia | 2006
G. Danelli; Massimiliano Nuzzi; Salcuni Pf; L. Caberti; M. Berti; E. Rossini; A. Casati; Guido Fanelli
Obesity Surgery | 2017
Federico Marchesi; Roberto Giacosa; Valeria Reggiani; Giuseppina De Sario; Francesco Tartamella; Elisa Melani; Maria Teresa Mita; Francesco Giovanni Cinieri; Stefano Cecchini; Matteo Riccò; Salcuni Pf; Luigi Roncoroni
Journal of Cardiovascular Surgery | 1995
Spaggiari L; Roberta R. Alfieri; Michele Rusca; Paolo Carbognani; Urbani S; Piergiorgio Petronini; L. Cattelani; Dal Corso Hm; Salcuni Pf; Angelo F. Borghetti
Journal of Cardiovascular Surgery | 1994
Lorenzo Spaggiari; Paolo Carbognani; Michele Rusca; Roberta R. Alfieri; Piergiorgio Petronini; L. Cattelani; Salcuni Pf; Angelo F. Borghetti; P. Bobbio